Back Pain

Pain·MeSH: Low Back Pain

Prevalence

8230.9 / 100K

Incidence

3488.0 / 100K/yr

17 drugs in development·7 companies·5 clinical trials

Drug Pipeline by Phase

Approved(1)

Drug	Company
Cymbalta®	ELI LILLY & Co (LLY)

Phase 2(4)

Drug	Company
allostemspine	CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)
dhea	GH Research PLC (GHRS)
lidopain	IMMUNE PHARMACEUTICALS INC (IMNP)
pregnenolone	GH Research PLC (GHRS)

Phase 1(5)

Drug	Company
AlloStemSpine® (CELZ-201 ADAPT)	CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)
AlloStemSpine® Chronic Lower Back Pain (CELZ-201 ADAPT)	CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)
AlloStem™ (CELZ-201-DDT)	CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)
CELZ-001	CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)
CELZ-201-DDT	CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)

Preclinical(5)

Drug	Company
basivertebral nerve ablation system	NeuroOne Medical Technologies Corporation (NMTC)
celz-100	CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)
ImmCelz™ (CELZ-100)	CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)
recet	NUTRA PHARMA CORP (NPHC)
spinal cord stimulation system	NeuroOne Medical Technologies Corporation (NMTC)

N/A(2)

Drug	Company
Local anesthetic	UNITED THERAPEUTICS Corp (UTHR)
StemSpine®	CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)

BioSniper tracks 17 drugs in development for Back Pain across 7 companies.

There are 5 clinical trials targeting Back Pain tracked by BioSniper.

The estimated prevalence of Back Pain is approximately 8230.9 per 100,000 population.

Full trial data, competitive analysis, and AI-powered pipeline tracking.